Search Results

A Phase III Study of Durvalumab (MEDI4736) With or Without Tremelimumab for Previously Treated Patients With Advanced NSCLC: Rationale and Protocol Design of the ARCTIC Study

by Planchard, David, Yokoi, Takashi, McCleod, Michael J., Fischer, Jürgen R., Kim, Young-Chul, Ballas, Marc, Shi, Kelvin, Soria, Jean-Charles
Published in Clinical Lung Cancer (2016)